Pseudohypoparathyroidism: genes and variants
Explore variant evidence for Pseudohypoparathyroidism across 2 analyzed proteins (GNAS, PTH1R). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 10 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pseudohypoparathyroidism
GNAS: Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
It produces the stimulatory G-alpha subunit that activates adenylyl cyclase downstream of many hormone receptors, with complex tissue-specific imprinting at the locus. Inactivating variants cause pseudohypoparathyroidism-spectrum disorders, while activating somatic variants cause McCune-Albright syndrome and some endocrine tumors.
13 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in GNAS have source records linked to Pseudohypoparathyroidism. Association strength is not clinical gene validity.
PTH1R: Parathyroid hormone/parathyroid hormone-related peptide receptor
It responds to parathyroid hormone and PTH-related peptide to coordinate calcium homeostasis and growth-plate development through cyclic-AMP and other pathways. Gain- and loss-of-function variants cause distinct skeletal disorders including Jansen metaphyseal chondrodysplasia and Blomstrand chondrodysplasia.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTH1R have source records linked to Pseudohypoparathyroidism. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pseudohypoparathyroidism
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GNAS R201H | 201 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R201C | 201 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R231C | 231 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R232C | 232 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS P115L | 115 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R228C | 228 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS R336W | 336 | G-alpha | Pathogenic / likely pathogenic (★★) |
| GNAS M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| GNAS P116L | 116 | G-alpha | Pathogenic / likely pathogenic (★★) |
| PTH1R D241E | 241 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GNAS L99P | 99 | G-alpha | Pathogenic / likely pathogenic |
| GNAS S250R | 250 | G-alpha | Pathogenic / likely pathogenic |
| GNAS S251R | 251 | G-alpha | Pathogenic / likely pathogenic |
| GNAS L388R | 388 | G-alpha | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Pseudohypoparathyroidism
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GNAS R232H | 232 | G-alpha | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; R232C at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.826 |
Same protein, different disease
- Pseudohypoparathyroidism type I A also has ClinVar records linked to GNAS variants; they fall mostly in different places as the Pseudohypoparathyroidism variants (29 pathogenic / likely pathogenic).
- Pseudopseudohypoparathyroidism also has ClinVar records linked to GNAS variants; they fall mostly in different places as the Pseudohypoparathyroidism variants (7 pathogenic / likely pathogenic).
- McCune-Albright syndrome also has ClinVar records linked to GNAS variants; they fall partly in the same places as the Pseudohypoparathyroidism variants (5 pathogenic / likely pathogenic).
- Metaphyseal chondrodysplasia, Jansen type also has ClinVar records linked to PTH1R variants; they fall mostly in different places as the Pseudohypoparathyroidism variants (5 pathogenic / likely pathogenic).
Diseases related to Pseudohypoparathyroidism
- Hereditary spastic paraplegia, also linked to GNAS
- Pseudohypoparathyroidism type I A, also linked to GNAS
- Connective tissue disease, also linked to PTH1R
- Osteoporosis, also linked to PTH1R
- Pseudopseudohypoparathyroidism, also linked to GNAS
- McCune-Albright syndrome, also linked to GNAS
- Metaphyseal chondrodysplasia, Jansen type, also linked to PTH1R
- Postmenopausal osteoporosis, also linked to PTH1R
- Chondrodysplasia Blomstrand type, also linked to PTH1R
- Pituitary adenoma 3, multiple types, also linked to GNAS
- Eiken syndrome, also linked to PTH1R
- Primary failure of tooth eruption, also linked to PTH1R
Frequently asked questions
Which genes have records linked to Pseudohypoparathyroidism?
This view contains 2 analyzed proteins: GNAS, PTH1R. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 10 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 62 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center